China Pharma Holdings Operating Expenses 2010-2025 | CPHI
China Pharma Holdings operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
China Pharma Holdings Annual Operating Expenses
(Millions of US $) |
| 2024 |
$9 |
| 2023 |
$10 |
| 2022 |
$12 |
| 2021 |
$13 |
| 2020 |
$13 |
| 2019 |
$31 |
| 2018 |
$23 |
| 2017 |
$32 |
| 2016 |
$24 |
| 2015 |
$35 |
| 2014 |
$61 |
| 2013 |
$51 |
| 2012 |
$49 |
| 2011 |
$59 |
| 2010 |
$50 |
| 2009 |
$39 |
China Pharma Holdings Quarterly Operating Expenses
(Millions of US $) |
| 2025-03-31 |
$2 |
| 2024-12-31 |
$2 |
| 2024-09-30 |
$2 |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$3 |
| 2023-09-30 |
$3 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$3 |
| 2021-06-30 |
$3 |
| 2021-03-31 |
$3 |
| 2020-12-31 |
$4 |
| 2020-09-30 |
$3 |
| 2020-06-30 |
$4 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$22 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
$3 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$11 |
| 2018-09-30 |
$4 |
| 2018-06-30 |
$4 |
| 2018-03-31 |
$4 |
| 2017-12-31 |
$18 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$5 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$8 |
| 2016-09-30 |
$5 |
| 2016-06-30 |
$6 |
| 2016-03-31 |
$5 |
| 2015-12-31 |
$20 |
| 2015-09-30 |
$1 |
| 2015-06-30 |
$4 |
| 2015-03-31 |
$9 |
| 2014-12-31 |
$25 |
| 2014-09-30 |
$12 |
| 2014-06-30 |
$15 |
| 2014-03-31 |
$9 |
| 2013-12-31 |
$17 |
| 2013-09-30 |
$11 |
| 2013-06-30 |
$13 |
| 2013-03-31 |
$11 |
| 2012-12-31 |
$13 |
| 2012-09-30 |
$11 |
| 2012-06-30 |
$12 |
| 2012-03-31 |
$13 |
| 2011-12-31 |
$18 |
| 2011-09-30 |
$15 |
| 2011-06-30 |
$14 |
| 2011-03-31 |
$13 |
| 2010-12-31 |
$16 |
| 2010-09-30 |
$12 |
| 2010-06-30 |
$11 |
| 2010-03-31 |
$10 |
| 2009-12-31 |
$14 |
| 2009-09-30 |
$7 |
| 2009-06-30 |
$9 |
| 2009-03-31 |
$9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.006B |
$0.005B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
